Feasibility and outcomes of crossflow membrane plasmapheresis for long COVID in Suriname: a randomized double-blind placebo-controlled pilot trial

F1000Research · Published 2026-08-05 · DOI 10.12688/f1000research.186744.1

Free full text

Authors (19)

Rosita Bihariesingh-Sanchit, Rakesh Bansie, Prija Paltoe, Rocade Ma, Debra Bustamente, Dhiradj Ramesar, Radha Raghosing-Sanchit, John Codrington, Inhya Ma-Bihariesingh, Stephen Vreden, Fey van der Dijs, Rishi Mangroo, Monique Simson, Navin Ramdhani, Cesar Fung A Foek, Angélique van 't Wout, Dimitri Diavatopoulos, Marien de Jonge, Arno Nierich

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Bihariesingh-Sanchit, R., Bansie, R., Paltoe, P., et al. (2026). Feasibility and outcomes of crossflow membrane plasmapheresis for long COVID in Suriname: a randomized double-blind placebo-controlled pilot trial. F1000Research. https://doi.org/10.12688/f1000research.186744.1

Related articles